← Leaderboards
Estelle B. Gauda
Johns Hopkins University
$5,876,566
Attributed
$5,876,566
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $950.7K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$5,876,566 · 6
By mechanism
R01$3,013,468 · 2
R25$1,654,554 · 1
R21$1,208,544 · 3
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Kenneth D. Karlin$16,339,237
- Maurice J Bessman$2,289,088
- Gayle Giboney Page$6,910,993
- Gary S Wand$18,956,510
- Elizabeth A Eipper$13,280,286
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseMediatingChemoreceptorsCarotid BodyNeurotransmittersEmbryo /Fetus ToxicologyUniversitiesResearch PersonnelAdverse EffectsPharmaceutical PreparationsLearningReportingProgramsOpiatesBirthGrantBreathingNih Program AnnouncementsBaseEnvironmental Air FlowNeuronsCholinergic ReceptorsDopamine Beta MonooxygenaseLaboratory Rat
Grant awards (28)
Immersion in Drug Abuse$335,679
R25 · FY2011 · DA · contact PI
Efficacy of clonidine in reducing iatrogenic-induced opioid dependence in infants$183,330
R21 · FY2011 · DA · contact PI
Efficacy of clonidine in reducing iatrogenic-induced opioid dependence in infants$11,621
R21 · FY2011 · DA · contact PI
Immersion in Drug Abuse$335,935
R25 · FY2010 · DA · contact PI
Efficacy of clonidine in reducing iatrogenic-induced opioid dependence in infants$157,500
R21 · FY2010 · DA · contact PI
Neuroplasticity and the carotid body$428,263
R01 · FY2009 · HL · contact PI
Immersion in Drug Abuse$329,441
R25 · FY2009 · DA · contact PI
Neuroplasticity and the carotid body$417,176
R01 · FY2008 · HL · contact PI
Immersion in Drug Abuse$319,846
R25 · FY2008 · DA · contact PI
DUAL ENZYME-BASED MICROBIOSENSOR TO MEASURE ATP RELEASE FROM THE CAROTID BODY$194,949
R21 · FY2008 · HL · contact PI
Immersion in Drug Abuse$18,738
R25 · FY2008 · DA · contact PI
Neuroplasticity and the carotid body$380,746
R01 · FY2007 · HL · contact PI
Immersion in Drug Abuse$314,915
R25 · FY2007 · DA · contact PI
DUAL ENZYME-BASED MICROBIOSENSOR TO MEASURE ATP RELEASE FROM THE CAROTID BODY$239,384
R21 · FY2007 · HL · contact PI
Neuroplasticity and the carotid body$383,344
R01 · FY2006 · HL · contact PI
Clonidine Treatment for Neonatal Abstinence Syndrome$122,063
R21 · FY2006 · DA · contact PI
Clonidine Treatment for Neonatal Abstinence Syndrome$29,754
R21 · FY2006 · DA · contact PI
Clonidine Treatment for Neonatal Abstinence Syndrome$86,500
R21 · FY2005 · DA
Clonidine Treatment for Neonatal Abstinence Syndrome$13,279
R21 · FY2005 · DA
Clonidine Treatment for Neonatal Abstinence Syndrome$6,664
R21 · FY2005 · DA
Nicotine induced neuroplasticity in the carotid body$371,717
R01 · FY2004 · DA
Nicotine induced neuroplasticity in the carotid body$14,267
R01 · FY2004 · DA
Nicotine induced neuroplasticity in the carotid body$327,000
R01 · FY2003 · DA
Clonidine Treatment for Neonatal Abstinence Syndrome$163,500
R21 · FY2003 · DA
Nicotine induced neuroplasticity in the carotid body$51,709
R01 · FY2003 · DA
Nicotine induced neuroplasticity in the carotid body$13,679
R01 · FY2003 · DA
Nicotine induced neuroplasticity in the carotid body$322,876
R01 · FY2002 · DA
Nicotine induced neuroplasticity in the carotid body$302,691
R01 · FY2001 · DA